Kyverna Therapeutics, Inc. Common Stock
KYTX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$9.74
Stop Loss
$8.36
Performance
-3.91%
Days Open
7
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 8, 2026
Open Price $9.74
Stop Loss $8.36
Timespan Day
Company Profile
Name Kyverna Therapeutics, Inc. Common Stock
Ticker KYTX
Market Cap $132.68M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $9.36
List Date Feb 8, 2024
Description
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
Website Open Company Website